NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

Shutterstock tomato image
Wake Forest University researchers have a $3 million NSF grant to study why tomato plants won’t bear fruit when things get hot.
Metabolon researchers in PPE
Morrisville precision health company Metabolon is working with a Seattle non-profit to study variations in COVID-19 outcomes and target potential therapies to deal with those variations.
AskBio generic photo
AskBio has acquired BrainVectis, a French company that is developing a potential gene therapy for Huntington’s disease, a fatal genetic disease of the brain.
Grifols' 233-acre manufacturing site in Clayton.
People who have recovered from COVID-19 may donate potentially lifesaving plasma at UNC, and Grifols is also collecting it at plasma donor sites elsewhere around the country.
LabCorp lab photo
Healthcare workers and first responders who have symptoms of COVID-19 now can use a LabCorp kit to self-test for the coronavirus at home.
RedHill logo
RedHill Biopharma is another step closer to getting one of its potential treatments for COVID-19 tested.
Shield developed by NC State for viral protection
Graduate student volunteers and faculty at NC State are producing personal protective equipment for healthcare workers across North Carolina.
Panaceutics production line
Panaceutics Nutrition, a provider of personalized nutrition products with operations in Research Triangle Park, has closed the first tranche of a committed funding round of over $5 million.
Composite berry stock photo
Durham food tech startup Pairwise enters agreement with California's Plant Sciences, Inc. to blend CRISPR gene-editing technology with germplasm of existing berries to create new varieties.
Cambrex logo
Cambrex Corp., a global provider of small-molecule drug services with growing operations in High Point and Durham, has finished an expansion of its biopharmaceutical analysis capabilities in Durham.
Mansukh Wani
Durham scientist Mansukh Wani, Ph.D., whose career at RTI International brought cancer drugs that saved countless lives, died of natural causes last Saturday at the age of 95.
BioPharm International April 2020 cover
The Raleigh-Durham area is one of the nation's fastest-growing metropolitan areas and offers the lowest operating costs of any major U.S. life science location, says John Boyd, CEO of the Boyd Company, a site selection advisory firm.
Shutterstock image of child, tin can on string
An unusual therapy under development by Fennec Pharmaceuticals is getting an expedited opportunity to protect the hearing of children undergoing chemotherapy.
Liquidia particles
The U.S. Food and Drug Administration has accepted Liquidia Technologies’ new drug application for its pulmonary arterial hypertension treatment, LIQ861.
Grid logo
Grid Therapeutics has received clearance from the U.S. Food and Drug Administration to begin human testing of its new cancer immunotherapy.